|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1995-7-27
|
|
pubmed:abstractText |
Pulmonary hypertension is characterized by abnormal thickening of the pulmonary arteries and increased pulmonary vascular resistance. Nitric oxide is a potent endothelium-derived vasorelaxant substance and an inhibitor of smooth-muscle-cell growth. Nitric oxide is produced in various cell types by the action of an enzyme, nitric oxide synthase. We compared the expression of endothelial nitric oxide synthase in the lungs of control subjects with that in the lungs of patients with pulmonary hypertension.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
333
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
214-21
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:7540722-Adult,
pubmed-meshheading:7540722-Amino Acid Oxidoreductases,
pubmed-meshheading:7540722-Case-Control Studies,
pubmed-meshheading:7540722-Endothelium, Vascular,
pubmed-meshheading:7540722-Epithelium,
pubmed-meshheading:7540722-Female,
pubmed-meshheading:7540722-Humans,
pubmed-meshheading:7540722-Hypertension, Pulmonary,
pubmed-meshheading:7540722-Lung,
pubmed-meshheading:7540722-Male,
pubmed-meshheading:7540722-Middle Aged,
pubmed-meshheading:7540722-NADPH Dehydrogenase,
pubmed-meshheading:7540722-Nitric Oxide Synthase,
pubmed-meshheading:7540722-Pulmonary Artery
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.
|
|
pubmed:affiliation |
Department of Pathology, Montreal General Hospital, Canada.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
